Document is current
Any future updates will be listed below
-
Authors
Zhang, Xudong
Zhang, Siwen
Qi, Jiarui
Zhao, Fujie
Lu, Yimeng
Li, Shuyu
Wu, Shanshan
Li, Pingping
Tan, Jichun https://orcid.org/0000-0002-6401-1919
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82071601, 82201791)
the Central Government Special Fund for Local Science and Technology Development (2020JH6/10500006)
the Natural Science Foundation Program of Liaoning Province (2018225093, 2022-YGJC-72)
the Major Special Construction Plan for Discipline Construction Project of China Medical University (3110118033)
the Shengjing Freelance Researcher Plan of Shengjing Hospital of China Medical University
the 345 talent project of Shengjing Hospital
- License Information
-
More Information
Article History
Received: 27 October 2022
Accepted: 14 April 2023
First Online: 28 April 2023
Declarations
:
: This study was approved by the Ethics Committee of the Shengjing Hospital of China Medical University (title of the approved project: Clinical and molecular mechanism study on the application of MenSCs-derived exosomes in the treatment of intrauterine adhesion; approval number: 2019PS012F; date of approval: 14th July 2019). All sample donors signed an informed consent statement. The study has been performed in accordance with the principles of Declaration of Helsinki.
: Not applicable.
: The authors have declared that no competing interest exists.
